Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995

$15.00 CAD

pp.xi, 273. library stamp on title page.paperback edition .”Networks of Innovation offers a historical perspective on the manner in which private sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp & Dohme, which acquired Mulford in 1929, and on Merck & Co., Inc., which merged with Sharp & Dohme in 1953. By surveying a century of innovation in biologicals, the authors show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad.”

In stock

SKU: U01134 Category:

Book Information

ISBN 052162620X
ISBN13 9780521626200
Number of pages 273
Original Title Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995
Published Date 1997
Book Condition Good
Jacket Condition No Dustjacket
Binding Paperback
Size 8vo
Place of Publication Cambridge
Edition First edition
Category:
Authors:,
Publisher:

Description

pp.xi, 273. library stamp on title page.paperback edition .”Networks of Innovation offers a historical perspective on the manner in which private sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp & Dohme, which acquired Mulford in 1929, and on Merck & Co., Inc., which merged with Sharp & Dohme in 1953. By surveying a century of innovation in biologicals, the authors show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad.”

Additional information

Weight 1 kg